CymaBay Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CBAY and other ETFs, options, and stocks.

About CBAY

CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. 

CEO
Sujal Shah
CEOSujal Shah
Employees
59
Employees59
Headquarters
Newark, California
HeadquartersNewark, California
Founded
1988
Founded1988
Employees
59
Employees59

CBAY Key Statistics

Market cap
347.11M
Market cap347.11M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
634.67K
Average volume634.67K
High today
$4.14
High today$4.14
Low today
$4.02
Low today$4.02
Open price
$4.13
Open price$4.13
Volume
353.66K
Volume353.66K
52 Week high
$4.30
52 Week high$4.30
52 Week low
$1.67
52 Week low$1.67

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

CBAY Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 16, After Hours
ActualExpected Mar 16, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.